Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers-Reference-Cited by-同舟云学术

Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers

Published:2017-02-16 Issue:8 Volume:13 Page:903-912
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Handels Ron L.H.¹,Vos Stephanie J.B.¹,Kramberger Milica G.²,Jelic Vesna³,Blennow Kaj⁴,Buchem Mark⁵,Flier Wiesje⁶⁷,Freund‐Levi Yvonne³⁸,Hampel Harald⁹¹⁰,Olde Rikkert Marcel¹¹,Oleksik Ania⁵,Pirtosek Zvezdan²,Scheltens Philip⁶,Soininen Hilkka¹²,Teunissen Charlotte¹³,Tsolaki Magda¹⁴,Wallin Asa K.¹⁵,Winblad Bengt³,Verhey Frans R.J.¹,Visser Pieter Jelle¹⁶

Affiliation:

1. Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neurosciences Maastricht University Maastricht The Netherlands

2. Department of Neurology Ljubljana University Medical Centre Ljubljana Slovenia

3. Division of Clinical Geriatrics, Department of NVS, Karolinska Institutet Center for Alzheimer Research Division of Neurogeriatrics Huddinge Sweden

4. Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital Mölndal Sweden

5. Department of Radiology Leiden University Medical Centre Leiden The Netherlands

6. Alzheimer Centre and Department of Neurology, Neuroscience Campus Amsterdam VU University Medical Centre Amsterdam The Netherlands

7. Department of Epidemiology and Biostatistics VU University Medical Center Amsterdam The Netherlands

8. Department of Psychiatry Tiohundra AB Norrtälje Hospital Stockholm Sweden

9. AXA Research Fund & UPMC Chair Paris France

10. Sorbonne Universités Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Département de Neurologie Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié‐Salpêtrière, Boulevard de l'hôpital Paris France

11. Department of Geriatrics, Radboudumc Alzheimer Centre, Donders Institute for Brain Cognition and Behavior Radboud University Medical Centre Nijmegen The Netherlands

12. Department of Neurology, Institute of Clinical Medicine , University of Eastern Finland, Neurocenter–Neurology, Kuopio University Hospital Kuopio Finland

13. Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry VU University Medical Centre Amsterdam The Netherlands

14. Memory and Dementia Outpatient Clinic, 3rd Department of Neurology, Medical School Aristotle University of Thessaloniki Thessaloniki Greece

15. Clinical Memory Research Unit, Department of Clinical Sciences Lund University Malmö Sweden

Funder

ZonMw

Javna Agencija za Raziskovalno Dejavnost RS

European Commission

Innovative Medicines Initiative

AXA Research Fund

The Netherlands Organisation for Health Research and Development

Health Research Council of the Academy of Finland

Swedish Research Council

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2016.12.015

Reference42 articles.

1. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

3. Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

4. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI

5. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Score to Predict Individual Risk for Future Alzheimer’s Disease: A Longitudinal Study of the ADNI Cohort;Journal of Alzheimer's Disease;2024-09-03

2. Machine Learning Classification of Patients with Amnestic Mild Cognitive Impairment and Non-Amnestic Mild Cognitive Impairment from Written Picture Description Tasks;Brain Sciences;2024-06-27

3. From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-04

4. A Machine Learning Classification of Individuals with Mild Cognitive Impairment into Variants from Writing;2024-02-19

5. Optimising Alzheimer’s Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment;The Journal of Prevention of Alzheimer's Disease;2024